PHARMING GRP SP. ADRS (PHG) — Cash Flow Reinvestment Rate
PHARMING GRP SP. ADRS (PHG) has a Cash Flow Reinvestment Rate of 0.05x as of December 2025, reinvesting €502.00K (capex €269.00K plus investments €233.00K) from operating cash flow of €10.71 Million. Check PHARMING GRP SP. ADRS cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
PHARMING GRP SP. ADRS Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for PHARMING GRP SP. ADRS across 3 annual periods. Explore PHARMING GRP SP. ADRS strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for PHARMING GRP SP. ADRS (2021–2025)
Year-by-year capital reinvestment analysis for PHARMING GRP SP. ADRS. For live market cap and broader valuation context, see PHG market cap.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.57x | €85.98 Million | €54.71 Million | €755.00K | ▲ +1685.3% |
| 2022 | 0.09x | €1.98 Million | €22.46 Million | €1.98 Million | ▼ -84.4% |
| 2021 | 0.56x | €21.30 Million | €37.84 Million | €16.72 Million | — |